SCHEMBL32669758

SCHEMBL32669758

CSc1ccc(F)c(CN(C)C(=O)/C(C#N)=C(\O)c2cc(Cl)c(O)c(Cl)c2)c1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
COMT P21964 1/20 0.36
FTO Q9C0B1 1/20 0.36
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
RIPK1 Q13546 1/20 0.31
HSD17B13 Q7Z5P4 1/20 0.31
MEN1 O00255 1/20 0.30
POLB P06746 1/20 0.30
MAPT P10636 1/20 0.30
GALK1 P51570 1/20 0.30
KMT2A Q03164 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
GAA P10253 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32669847 0.89 COMT (0.39) COMTFTOALDH1A1NPC1RAB9A
SCHEMBL32669600 0.87 ALDH1A1 (0.39) COMTFTOALDH1A1KDM4ENPC1
SCHEMBL32669621 0.86 COMT (0.37) COMTFTOALDH1A1MAOAMAOB
SCHEMBL32669498 0.86 COMT (0.39) COMTFTOALDH1A1NPC1RAB9A
SCHEMBL32670065 0.84 MCL1 (0.38) COMTFTOKDM4ENPC1MEN1
SCHEMBL32669572 0.82 COMT (0.40) COMTFTOALDH1A1RIPK1MEN1
SCHEMBL32669543 0.81 FFAR1 (0.37) COMTFTOALDH1A1RIPK1
SCHEMBL32669838 0.81 COMT (0.35) COMTFTOMAOAMAOB
SCHEMBL32670105 0.81 ALDH1A1 (0.37) COMTFTOALDH1A1KDM4EMAOA
SCHEMBL32669695 0.80 COMT (0.35) COMTFTONPC1RAB9AMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035341-A1 FTO INHIBITORS RPXDS CO LTD (CN) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035341-A1 FTO INHIBITORS FTO, LDLR, GPR119 COMT 52/4885FTO 1/4885ALDH1A1 1334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.